In PD rats, DRD1 activated by acetyl‐L‐carnitine attenuates microglial activation and the release of proinflammatory mediators, a phenomenon potentially linked to the amelioration of cognitive deficits and neurodegeneration (Singh, Mishra, Mohanbhai, et al., 2018). This evidence concerns the gene DRD1 and Parkinson disease.